Concepedia

James E. Ward

JE

10

Publications

788

Citations

10

H-Index

2000

Active since

Affiliations

Mayo Clinic in Arizona(Current)

AbbVie (United States)

University College London

Peter MacCallum Cancer Centre

São Germano Oncologia

James E. Ward is an author at Mayo Clinic in Arizona specializing in medicine, oncology, and radiation oncology.

Top concepts

Publications per year

2000–2023

10

Publications

10

Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial

Shaji Kumar, Simon J. Harrison, Michèle Cavo et al. · The Lancet Oncology · 2020 · 390 citations

, , +7

Resveratrol acts as an estrogen receptor (ER) agonist in breast cancer cells stably transfected with ER α

Anait S. Levenson, Barry D. Gehm, Sandra Timm Pearce et al. · International Journal of Cancer · 2003 · 118 citations · Full text

Clinical Response of a Patient to Anti–PD-1 Immunotherapy and the Immune Landscape of Testicular Germ Cell Tumors

Shalin Shah, James E. Ward, Riyue Bao et al. · Cancer Immunology Research · 2016 · 61 citations · Full text

, , +18

Selective MCL-1 inhibitor ABBV-467 is efficacious in tumor models but is associated with cardiac troponin increases in patients

Junichiro Yuda, Christine Will, Darren C. Phillips et al. · Communications Medicine · 2023 · 52 citations · Full text

Updated Analysis of Bellini, a Phase 3 Study of Venetoclax or Placebo in Combination with Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma

Philippe Moreau, Simon J. Harrison, Michèle Cavo et al. · Blood · 2019 · 38 citations

Rows per page

1–5 of 10